AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 5 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -50.0% | 1,850 | -35.1% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 2,850 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 2,850 | +54.1% | 0.00% | – |
| Q1 2019 | $2,000 | -85.7% | 1,850 | -78.3% | 0.00% | – |
| Q4 2018 | $14,000 | -33.3% | 8,540 | +30.6% | 0.00% | – |
| Q3 2018 | $21,000 | +75.0% | 6,540 | +58.0% | 0.00% | – |
| Q2 2018 | $12,000 | 0.0% | 4,140 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | +140.0% | 4,140 | +123.8% | 0.00% | – |
| Q4 2017 | $5,000 | -28.6% | 1,850 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | +600.0% | 1,850 | +640.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 250 | +21.4% | 0.00% | – |
| Q1 2014 | $0 | – | 206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,590,673 | $1,399,000 | 1.00% |
| Deer VI & Co. LLC | 675,242 | $365,000 | 0.28% |
| Sarissa Capital Management LP | 1,700,000 | $917,000 | 0.25% |
| NEA Management Company, LLC | 10,362,694 | $5,596,000 | 0.22% |
| Perceptive Advisors | 3,108,808 | $1,678,000 | 0.12% |
| Cormorant Asset Management, LP | 1,087,715 | $587,000 | 0.08% |
| 683 Capital Management, LLC | 1,000,000 | $540,000 | 0.04% |
| Spark Investment Management LLC | 95,800 | $51,000 | 0.00% |
| Elgethun Capital Management | 10,000 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,738 | $8,000 | 0.00% |